BONDRONAT Side Effects

6977050-4 | Bone Pain
on Sep 01, 2010 Female patient from GERMANY , weighting 134.5 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain. Bondronat dosage: . During the same period patient was treated with METAMIZOL (View Metamizol Review and Metamizol Label ). Patient was hospitalized.

6916674-7 | Epistaxis
Patient was taking Bondronat (View Usage). Patient had the following side effects: epistaxis on Jul 28, 2010 from GERMANY Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with metastases to bone and. Bondronat dosage: Third Cycle. During the same period patient was treated with BEVACIZUMAB (Third Cycle) (View Bevacizumab Review and Bevacizumab Label ), TAXOTERE (Cycle 3) (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6877128-X | Abdominal Pain Upper, Angina Pectoris, Asthenia, Bone Disorder, Diarrhoea, Fatigue, Gastric Disorder, Gastric Haemorrhage, Hallucination
Adverse event was reported on Jul 19, 2010 by a Female patient taking Bondronat (View Usage) (Dosage: Dose: Single Dose Every 14 Days) was diagnosed with breast cancer female and. Location: GERMANY , 71 years of age, weighting 103.6 lb, After Bondronat was administered, patient had the following side effects: abdominal pain upper, angina pectoris, asthenia, bone disorder, diarrhoea, fatigue, gastric disorder, gastric haemorrhage, hallucination. During the same period patient was treated with AROMASIN (Form: Coated Tablet) (View Aromasin Review and Aromasin Label ). Patient was hospitalized.

6862720-9 | Deep Vein Thrombosis, Diarrhoea, Malignant Neoplasm Progression, Pneumonia, Pulmonary Embolism
on Jul 12, 2010 Female patient from GERMANY , weighting 165.3 lb, was diagnosed with prophylaxis, antiemetic supportive care, sleep disorder (What is sleep disorder?), gastric disorder and was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), diarrhoea, malignant neoplasm progression, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). Bondronat dosage: . During the same period patient was treated with BEVACIZUMAB (Administration On Days 1 And 15) (View Bevacizumab Review and Bevacizumab Label ), DEXAMETHASONE TAB (Administration On Days 1, 8 And 15) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), TAXOL (Administration On Days 1, 8 And 15) (View Taxol Review and Taxol Label ), METOHEXAL SUCC (View Metohexal Succ Review and Metohexal Succ Label ), MCP RATIOPHARM (Intake As Needed) (View Mcp-ratiopharm Review and Mcp-ratiopharm Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PANTOPRAZOL (View Pantoprazol Review and Pantoprazol Label ). Patient was hospitalized.


6785139-8 | Osteonecrosis Of Jaw
on Mar 25, 2010 Female patient from GERMANY , 86 years of age, was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis of jaw. Bondronat dosage: .

6756322-2 | Pyrexia
Patient was taking Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: pyrexia on May 27, 2010 from GERMANY Additional patient health information: Male patient , 77 years of age, weighting 130.5 lb, . Bondronat dosage: Strength: 2 Mg/2ml. During the same period patient was treated with PANTOZOL (View Pantozol Review and Pantozol Label ), METOCLOPRAMID HCL (View Metoclopramid-hcl Review and Metoclopramid-hcl Label ), NULYTELY (View Nulytely Review and Nulytely Label ), IDEOS (View Ideos Review and Ideos Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FURORESE (View Furorese Review and Furorese Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6749460-1 | Blood Pressure Increased, Panic Attack, Polyneuropathy, Sleep Disorder
Adverse event was reported on May 19, 2010 by a Female patient taking Bondronat (View Usage) (Dosage: Given Once) was diagnosed with osteoporosis (What is osteoporosis?), breast cancer (What is breast cancer?) and. Location: GERMANY , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, panic attack, polyneuropathy, sleep disorder (What is sleep disorder?). During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), BETA BLOCKER (View Beta-blocker Review and Beta-blocker Label ).

6657950-5 | Osteonecrosis
on Mar 25, 2010 Female patient from GERMANY , 86 years of age, was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: .

6571895-0 | Cataract, Lenticular Opacities
on Feb 01, 2010 Female patient from GERMANY , weighting 141.1 lb, was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: cataract (What is cataract?), lenticular opacities. Bondronat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), BISOPROLOL COMP (Reported As Bisoprolol Dura Plus.) (View Bisoprolol Comp Review and Bisoprolol Comp Label ).

6517543-7 | Hypercalcaemia, Renal Failure, Renal Tubular Necrosis
Patient was taking Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia, renal failure, renal tubular necrosis on Dec 14, 2009 from GERMANY Additional patient health information: Female patient , weighting 110.2 lb, . Bondronat dosage: Taken Once. During the same period patient was treated with METAMIZOL (2-4 Times Daily) (View Metamizol Review and Metamizol Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ).

6407090-5 | Blood Creatinine Increased, Hyperkalaemia, Renal Failure Acute, Somnolence
Adverse event was reported on Oct 13, 2009 by a Female patient taking Bondronat (View Usage) (Dosage: Intravenous (nos) Form: Infusion Frequency: Once) was diagnosed with metastatic pain and. Location: GERMANY , 90 years of age, weighting 172.0 lb, Patient had the following side effects: blood creatinine increased, hyperkalaemia, renal failure acute, somnolence.

6406855-3 | Lenticular Opacities
on Oct 15, 2009 Female patient from GERMANY , weighting 141.1 lb, was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: lenticular opacities. Bondronat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), BISOPROLOL COMP (Reported As Bisoprolol Dura Plus.) (View Bisoprolol Comp Review and Bisoprolol Comp Label ).

6395240-9 | Lenticular Opacities
on Sep 30, 2009 Female patient from GERMANY , weighting 141.1 lb, was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: lenticular opacities. Bondronat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), BISOPROLOL COMP (Reported As Bisoprolol Dura Plus.) (View Bisoprolol Comp Review and Bisoprolol Comp Label ).

6357755-9 | Dysphonia, Epiglottitis, Tracheitis
Patient was taking Bondronat (View Usage). Patient had the following side effects: dysphonia, epiglottitis, tracheitis on Sep 01, 2009 from CUBA Additional patient health information: Female patient , 50 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Bondronat dosage: Dose-6 Mg/6 Ml. During the same period patient was treated with VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ).

6299354-3 | Blood Creatinine Increased
Adverse event was reported on Jul 24, 2009 by a Female patient taking Bondronat (View Usage) (Dosage: ) . Location: SWEDEN , 76 years of age, After Bondronat was administered, patient had the following side effects: blood creatinine increased. During the same period patient was treated with ALVEDON (View Alvedon Review and Alvedon Label ), FEMAR (View Femar Review and Femar Label ). Patient was hospitalized.

6275071-0 | Blood Creatinine Increased
on Jul 16, 2009 Female patient from SWEDEN , 76 years of age, was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased. Bondronat dosage: . During the same period patient was treated with ALVEDON (View Alvedon Review and Alvedon Label ), FEMAR (View Femar Review and Femar Label ). Patient was hospitalized.

6263640-3 | Blood Creatinine Increased
on Jul 02, 2009 Female patient from SWEDEN , 77 years of age, was treated with Bondronat (View Usage). Patient had the following side effects: blood creatinine increased. Bondronat dosage: . During the same period patient was treated with ALVEDON (View Alvedon Review and Alvedon Label ), FEMAR (View Femar Review and Femar Label ). Patient was hospitalized.

6194570-3 | Teeth Brittle
Patient was taking Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: teeth brittle on May 08, 2009 from GERMANY Additional patient health information: Female patient , weighting 112.4 lb, . Bondronat dosage: .

6017212-6 | Osteonecrosis
Adverse event was reported on Dec 08, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: Frequency: Daily) was diagnosed with breast cancer metastatic, pain (What is pain?), nausea (What is nausea?), anxiety (What is anxiety?) and. Location: UNITED KINGDOM , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), MORPHINE SULFATE (Dosing Amount: Variable) (View Morphine Sulfate Review and Morphine Sulfate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), WARFARIN (Dosing Amount: Variable) (View Warfarin Review and Warfarin Label ), CYCLIZINE (Start Date: Intermittent) (View Cyclizine Review and Cyclizine Label ), DIAZEPAM (Frequency Rptd As : Prn) (View Diazepam Review and Diazepam Label ), SYMBICORT (Long Term) (View Symbicort Review and Symbicort Label ), ORAMORPH SR (Frequency: Prn) (View Oramorph Sr Review and Oramorph Sr Label ).

5956775-3 | Osteonecrosis
on Nov 05, 2008 Female patient from SWITZERLAND , 52 years of age, was diagnosed with breast cancer metastatic and was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), FEMARA (View Femara Review and Femara Label ), FLUANXOL (View Fluanxol Review and Fluanxol Label ), LITHIUM (View Lithium Review and Lithium Label ).

5956766-2 | Arrhythmia, Asthenia, Candidiasis, Dysgeusia, Dyspnoea, Haemoglobin Decreased, Muscle Spasms, Myalgia, Pleural Effusion
on Nov 06, 2008 Female patient from GERMANY , weighting 114.6 lb, was diagnosed with analgesia and was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), asthenia, candidiasis, dysgeusia, dyspnoea, haemoglobin decreased, muscle spasms, myalgia, pleural effusion. Bondronat dosage: Route: Infusion.. During the same period patient was treated with PALLADONE (View Palladone Review and Palladone Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), DEXA (View Dexa Review and Dexa Label ).

5929430-3 | Osteonecrosis
Patient was taking Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?) on Oct 16, 2008 from SWEDEN Additional patient health information: Female patient , 54 years of age, . Bondronat dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ).

5888033-X | Breast Cancer, Gastric Disorder, Osteonecrosis
Adverse event was reported on Aug 25, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: Dose; 6 Mg In 15 Minutes. Patient Received Single Dose Of Iv Ibandronic Acid) was diagnosed with disease progression and. Location: UNITED STATES , 78 years of age, Patient had the following side effects: breast cancer (What is breast cancer?), gastric disorder, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with NAVELBINE (Dose: 60 Mg/m2 Weekly) (View Navelbine Review and Navelbine Label ), MYOCET (View Myocet Review and Myocet Label ), MEGACE (View Megace Review and Megace Label ).

5873745-4 | Breast Cancer, Gastric Disorder, Malignant Neoplasm Progression, Metastases To Bone, Metastases To Liver, Osteonecrosis, Therapeutic Response Decreased
on Aug 25, 2008 Female patient from UNITED STATES , 78 years of age, was diagnosed with disease progression and was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: breast cancer (What is breast cancer?), gastric disorder, malignant neoplasm progression, metastases to bone, metastases to liver, osteonecrosis (What is osteonecrosis?), therapeutic response decreased. Bondronat dosage: Dose; 6 Mg In 15 Minutes. Patient Received Single Dose Of Iv Ibandronic Acid. During the same period patient was treated with NAVELBINE (Dose: 60 Mg/m2 Weekly) (View Navelbine Review and Navelbine Label ), MYOCET (View Myocet Review and Myocet Label ), MEGACE (View Megace Review and Megace Label ).

5856303-7 | Jaw Cyst, Osteonecrosis
on Aug 13, 2008 Male patient from GERMANY , 70 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: jaw cyst, osteonecrosis (What is osteonecrosis?). Bondronat dosage: .

5854010-8 | Abscess, Infection, Oral Disorder, Oral Mucosa Erosion, Osteonecrosis, Pain In Jaw, Paraesthesia, Swelling
Patient was taking Bondronat (View Usage). Patient had the following side effects: abscess (What is abscess?), infection (What is infection?), oral disorder, oral mucosa erosion, osteonecrosis (What is osteonecrosis?), pain in jaw, paraesthesia, swelling on Aug 13, 2008 from DENMARK Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with breast cancer metastatic and. Bondronat dosage: Form: Film-coated Tablet.. During the same period patient was treated with ZOMETA (Form Reported As Pow. And Solv.) (View Zometa Review and Zometa Label ), ARIMIDEX (Form: Film-coated Tablet.) (View Arimidex Review and Arimidex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5847924-6 | Osteonecrosis
Adverse event was reported on Aug 04, 2008 by a Male patient taking Bondronat (View Usage) (Dosage: ) was diagnosed with metastases to bone and. Location: UNITED KINGDOM , weighting 143.3 lb, After Bondronat was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), INTERFERON (View Interferon Review and Interferon Label ), MEGACE (View Megace Review and Megace Label ).

5847919-2 | Dyspnoea, Haemoglobin Decreased, Herpes Zoster, Osteonecrosis
on Aug 04, 2008 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with osteolysis and was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, haemoglobin decreased, herpes zoster, osteonecrosis (What is osteonecrosis?). Bondronat dosage: Form Reported: Infusion.

5833872-4 | Osteonecrosis
on Jul 24, 2008 Female patient from GERMANY , weighting 160.9 lb, was diagnosed with osteoporotic fracture and was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: .

5833868-2 | Osteonecrosis
Patient was taking Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Jul 24, 2008 from GERMANY Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with breast cancer (What is breast cancer?) and. Bondronat dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

5827266-5 | Osteonecrosis
Adverse event was reported on Jul 29, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: ) . Location: AUSTRIA , weighting 169.3 lb, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with BEVACIZUMAB (Form Reported As ^fluid^.) (View Bevacizumab Review and Bevacizumab Label ), DOCETAXEL (Form Reported As ^fluid^.) (View Docetaxel Review and Docetaxel Label ), ACECOMB (View Acecomb Review and Acecomb Label ), RABEPRAZOL (Durg Reported As ^rabeprazol Natrium^.) (View Rabeprazol Review and Rabeprazol Label ), SUPRADYN (View Supradyn Review and Supradyn Label ), NIMESULID (Dose - As Needed) (View Nimesulid Review and Nimesulid Label ), LYMPHDIARAL (Total Daily Dose Reported As ^na^.) (View Lymphdiaral Review and Lymphdiaral Label ). Patient was hospitalized.

5809596-6 | Osteonecrosis
on Jul 04, 2008 Female patient from GERMANY , 72 years of age, was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: .

5806218-5 | Oral Disorder, Osteonecrosis
on Jul 03, 2008 Female patient from GERMANY , 66 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: oral disorder, osteonecrosis (What is osteonecrosis?). Bondronat dosage: .

5752221-3 | Erythema, Extravasation, Localised Oedema, Pain
Patient was taking Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, extravasation, localised oedema, pain (What is pain?) on May 19, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Bondronat dosage: . Patient was hospitalized.

5752220-1 | Abscess, Infection, Oral Disorder, Oral Mucosa Erosion, Osteonecrosis, Pain In Jaw, Paraesthesia, Swelling
Adverse event was reported on May 19, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: Form: Film-coated Tablet. Indication: C. Mammae With Bony Metastasis.) was diagnosed with breast cancer (What is breast cancer?) and. Location: DENMARK , weighting 125.7 lb, Patient had the following side effects: abscess (What is abscess?), infection (What is infection?), oral disorder, oral mucosa erosion, osteonecrosis (What is osteonecrosis?), pain in jaw, paraesthesia, swelling. During the same period patient was treated with ZOMETA (Form Reported As Pow. And Solv.) (View Zometa Review and Zometa Label ), ARIMIDEX (Form: Film-coated Tablet.) (View Arimidex Review and Arimidex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5749251-4 | Hepatitis
on May 15, 2008 Female patient from ICELAND , 60 years of age, was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: hepatitis (What is hepatitis?). Bondronat dosage: . During the same period patient was treated with LAMISIL (View Lamisil Review and Lamisil Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ).

5743707-6 | Bone Disorder, Infection, Mucous Membrane Disorder, Osteonecrosis, Pain In Jaw, Paraesthesia, Swelling
on May 09, 2008 Female patient from DENMARK , weighting 125.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, infection (What is infection?), mucous membrane disorder, osteonecrosis (What is osteonecrosis?), pain in jaw, paraesthesia, swelling. Bondronat dosage: Form: Film-coated Tablet. Indication: C. Mammae With Bony Metastasis.. During the same period patient was treated with ZOMETA (Form Reported As Pow. And Solv.) (View Zometa Review and Zometa Label ), ARIMIDEX (Form: Film-coated Tablet.) (View Arimidex Review and Arimidex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5734824-5 | Erythema, Extravasation, Injection Site Oedema, Injection Site Pain
Patient was taking Bondronat (View Usage). Patient had the following side effects: erythema, extravasation, injection site oedema, injection site pain on Apr 29, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Bondronat dosage: . Patient was hospitalized.

5723651-0 | Osteonecrosis
Adverse event was reported on Apr 23, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: Dosing Regimen Reported As: 50 Mgx1.) . Location: FINLAND , 80 years of age, After Bondronat was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?).

5670779-X | Osteonecrosis
on Mar 07, 2008 Female patient from DENMARK , 66 years of age, weighting 125.7 lb, was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: Form: Film-coated Tablet.. During the same period patient was treated with ZOMETA (Form Reported As Pow. And Solv.) (View Zometa Review and Zometa Label ), ARIMIDEX (Form: Film-coated Tablet.) (View Arimidex Review and Arimidex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5655348-X | Disease Progression, Ill-defined Disorder, Metastases To Bone
on Feb 25, 2008 Female patient from GERMANY , 57 years of age, was treated with Bondronat (View Usage). Patient had the following side effects: disease progression, ill-defined disorder, metastases to bone. Bondronat dosage: . During the same period patient was treated with ZOMETA (Form: Infusion) (View Zometa Review and Zometa Label ). Patient was hospitalized.

5645112-X | Oral Cavity Fistula, Osteonecrosis
Patient was taking Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: oral cavity fistula, osteonecrosis (What is osteonecrosis?) on Feb 20, 2008 from GERMANY Additional patient health information: Male patient , 70 years of age, . Bondronat dosage: .

5645111-8 | Osteonecrosis, Toothache
Adverse event was reported on Feb 18, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: Form Film Coated Tablet.) . Location: DENMARK , 65 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?), toothache.

5630880-3 | Osteonecrosis, Toothache
on Feb 08, 2008 Female patient from DENMARK , 65 years of age, weighting 176.4 lb, was treated with Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?), toothache. Bondronat dosage: Form Film Coated Tablet.

5630106-0 | Osteonecrosis
on Feb 08, 2008 Female patient from GERMANY , weighting 183.0 lb, was diagnosed with plasmacytoma, musculoskeletal pain and was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: 6 Mg, Qmo. During the same period patient was treated with PREDNISOLONE (1 To 10 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ).

5627922-8 | Osteonecrosis
Patient was taking Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?) on Feb 05, 2008 from SWEDEN Additional patient health information: Female patient , 66 years of age, . Bondronat dosage: Dose: 50mgx1. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ATENOLOL (Dose: 25mgx1) (View Atenolol Review and Atenolol Label ), FURIX (View Furix Review and Furix Label ), VOLTAREN GEL (View Voltaren Gel Review and Voltaren Gel Label ), PREDNISOLONE (At Present Taking 10mg/day) (View Prednisolone Review and Prednisolone Label ), KALIUM RETARD (View Kalium Retard Review and Kalium Retard Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KALCIPOS (Dose Reported As D1x1) (View Kalcipos Review and Kalcipos Label ).

5626397-2 | Osteomyelitis, Periostitis
Adverse event was reported on Feb 06, 2008 by a Female patient taking Bondronat (View Usage) (Dosage: ) . Location: FRANCE , 40 years of age, weighting 127.9 lb, Patient had the following side effects: osteomyelitis, periostitis. During the same period patient was treated with TAXOTERE (Received On 1-dec-2006, 27-dec-2006 And 23-feb-2007.) (View Taxotere Review and Taxotere Label ).

5615762-5 | Osteonecrosis
on Jan 31, 2008 Male patient from ITALY , 73 years of age, was diagnosed with breast cancer stage iv and was treated with Bondronat (View Usage). After Bondronat was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: . During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ). Patient was hospitalized.

5614005-6 | Osteonecrosis
on Jan 24, 2008 Female patient from SWEDEN , 88 years of age, was treated with Bondronat (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Bondronat dosage: Form: Concentrate For Solution For Infusion, Strength: 6 Mg/6 Ml, Dosage: 6 Mgc Mg C. During the same period patient was treated with ZOMETA (Form: Concentrate For Solution For Infusion, Strength: 4 Mg/5 Ml, Dosage: 4 Mgc Mg C) (View Zometa Review and Zometa Label ), COZAAR (Form: Film-coated Tablet) (View Cozaar Review and Cozaar Label ), FEMARA (View Femara Review and Femara Label ).

5612377-X | Osteonecrosis, Tooth Disorder
Patient was taking Bondronat (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?), tooth disorder (What is tooth disorder?) on Jan 21, 2008 from CZECH REPUBLIC Additional patient health information: Female patient , 69 years of age, was diagnosed with prophylaxis, multiple myeloma (What is multiple myeloma?), anaemia and. Bondronat dosage: Received Every 3 To 4 Weeks. During the same period patient was treated with BONEFOS (View Bonefos Review and Bonefos Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), MELFALAN (View Melfalan Review and Melfalan Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).